KORU Medical Systems and EMED Technologies Corporation Announce Settlement of All Pending Litigation
May 26 2020 - 8:00AM
Business Wire
Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ:
KRMD) (“KORU Medical”) and EMED Technologies Corporation
(“EMED”) today announced the settlement of all ongoing litigation
between the two companies, including patent, antitrust, unfair
business practice, and other business tort claims.
The agreement provides KORU Medical with freedom to operate
under EMED’s existing patent portfolio, dismissal of all litigation
with prejudice, and an equity payment by KORU Medical to EMED.
About KORU Medical
Systems
KORU Medical Systems manufactures and commercializes innovative
and easy-to-use specialty infusion solutions that improve quality
of life for patients around the world. The FREEDOM Syringe Infusion
System currently includes the FREEDOM60® and FreedomEdge® Syringe
Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo
Subcutaneous Safety Needle Sets™. These devices are used for
infusions administered in the home and alternate care settings. For
more information about the Company, please visit
www.korumedical.com.
Forward-looking
Statements
This press release may contain forward-looking statements that
involve risks and uncertainties. Actual results may differ
materially from the results predicted and reported results should
not be considered as an indication of future performance. The
potential risks and uncertainties that could cause actual results
to differ from the results predicted include, among others, those
risks and uncertainties included under the captions “Risk Factors”
in our Annual Report on Form 10-K for the year ended December 31,
2019, as amended, and our most recent Quarterly Report on Form 10-Q
for the quarter ended September 30, 2019, which are on file with
the SEC and are available on our website at
www.korumedical.com/investors and on the SEC website at
www.sec.gov. Additional information will also be set forth in our
Annual Report on Form 10-K for the year ended December 31, 2019.
All information provided in this release and in the attachments is
as of February 25, 2020. Undue reliance should not be placed on the
forward-looking statements in this press release, which are based
on information available to us on the date hereof. We undertake no
duty to update this information unless required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200526005179/en/
The Equity Group Inc. Devin Sullivan Senior Vice
President 212-836-9608 dsullivan@equityny.com
Kalle Ahl, CFA Vice President 212-836-9614 kahl@equityny.com
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Apr 2023 to Apr 2024